
Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …

The Sandwich Discovery Park in Kent has found new owners, 18 months after Pfizer decided to pull out from the …
Pfizer has begun talks with a real estate investor to sell its R&D centre in Sandwich. The site was Pfizer’s …

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …

Seven former Pfizer employees have set up a new business in Sandwich that will provide outsourcing services for the pharma …

Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing …

Pfizer has expanded its options for its main European research site, earmarked for closure in Feburary, and is now marketing …

Pfizer’s efforts to attract contract research organisations to take over part of its Sandwich research site will only benefit a …
Pharmaceutical industry leaders are increasingly admitting that the very low productivity of its R&D pipelines is unsustainable – but no …
The government has pledged around £775 million for translational research, saying it will help modernise the health service and support …

Science in the UK will have to focus on contractually-based research in the future as pharma’s R&D presence in the …
Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …

The political fallout over Pfizer’s decision to close its Kent R&D base continues apace, with the House of Commons to …